poisar

Stocks · News reference

HCW Biologics, Partners Identify TGF-β Trap, IL-15 Fusion As Novel Moiety With Potential Applications Against Diseased Cell, Viral Infections

BenzingaAug 25, 2026, 1:02 PMBenzinga Newsdesk

HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on developing novel fusion immunotherapeutics to treat autoimmune

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 25, 2026, 1:02 PM
Checked
Aug 25, 2026, 1:02 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading